Search company, investor...

Compare Molecular Staging vs Neuromedical Systems

Customers evaluate the quality of Molecular Staging's products using the following success metrics.

Overview

Molecular Staging is 26 yrs old and is based in United States.

Molecular Staging Inc. is a private, life sciences tool company developing a portfolio of technologies for the detection and measurement of proteins and nucleic acids across a broad range of applications, including proteomics, genomics, pharmacogenomics and diagnostics. MSI's core technology is Rolling Circle Amplification Technology (RCAT), an isothermal amplification process for detecting and measuring all classes of biomolecules including protein, DNA, and RNA. RCAT has significant advantages in dynamic range, scalability, sensitivity, multiplexing and flexibility over older methods, such as PCR. RCAT is the only molecular amplification method that aims to allow target recognition, signal amplification, and detection all to be performed directly on a microarray. The technology is compatible with many existing instrument platforms and is ideally suited for multiplexing assays in liquid and solid phase and direct amplification in cells and tissues. MSI is located in New Haven, Connecticut.

Neuromedical Systems is based in United States

Neuromedical Systems, Inc. a development stage company develops, manufactures and markets systems for computer assisted screening of pap smears and other cytological specimans. The company's product papnet testing system is used in laboratories in detection of abnormal cells on pap smears. Papnet is also used in detection of bladder and lung cancer. During the year, the company acquired New System International, Ltd. The company has international operations in Europe, Israel, Asia and Australia.

Country

United States

Demo Video

Demo not available because Molecular Staging has not claimed their profile.

Work for Molecular Staging? Show off your product.

Demo not available because Neuromedical Systems has not claimed their profile.

Work for Neuromedical Systems? Show off your product.

Leadership

Richard W Barker (Chief Executive Officer)

See all 5 people

David Duncan (Chief Financial Officer)

See all 3 people

Funding

Neuromedical Systems last raised $9.65M on 7/1/1995.

Total Raised

Investors

QIAGEN, Cooper Hill Partners

See all 5 investors

Edelson Technology Partners

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Molecular Staging has not claimed their profile.

Work for Molecular Staging? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Molecular Staging?

Claim your profile now.

Information not available because Neuromedical Systems has not claimed their profile.

Work for Neuromedical Systems? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Neuromedical Systems?

Claim your profile now.